
Company Info
Phone(510) 970-6000
Year Established
1996
Ticker
SGMO
Exchange
NASDAQ
Contacts
Stephanie J. Seiler, CLPHead of Business Development & Alliance Management
Nathalie Dubois-Stringfellow, Ph.D.
CDO
Sandy Macrae, M.B., Ch.B., Ph.D.
CEO
Prathyusha Duraibabu, CPA, MBA
CFO
Scott Willoughby
General Counsel
Company Description
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation.